Walleye Capital LLC Gossamer Bio, Inc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $1.53 Million - $4.66 Million	1,594,454 Added 8728.6%	1,612,721 $2.03 Million
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $31,784 - $235,096	18,267 New	18,267 $39,000
Q2 2022 Aug 08, 2022	BUY	$5.97 - $9.97 $1.82 Million - $3.04 Million	304,541 Added 120.46%	557,366 $4.67 Million
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $600,936 - $889,300	71,201 Added 39.2%	252,825 $2.2 Million
Q4 2021 Mar 03, 2022	BUY	$10.12 - $14.07 $1.84 Million - $2.56 Million	181,624 New	181,624 $2.05 Million
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $216,024 - $263,279	-27,003 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $233,035 - $295,412	27,003 New	27,003 $250,000
Q2 2020 Aug 14, 2020	SELL	$9.52 - $15.98 $34,519 - $57,943	-3,626 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.0 - $15.48 $29,008 - $56,130	3,626 New	3,626 $37,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.